Xanthine Oxidase Inhibitor Withdrawal Syndrome? Comment on the Article by Choi et al

Arthritis Rheumatol. 2019 Nov;71(11):1966-1967. doi: 10.1002/art.41066. Epub 2019 Sep 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Allopurinol
  • Febuxostat
  • Gout*
  • Humans
  • Rheumatology*
  • United States
  • United States Food and Drug Administration
  • Xanthine Oxidase

Substances

  • Febuxostat
  • Allopurinol
  • Xanthine Oxidase